AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030.

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more ...

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week, highlighting reports from Amazon, Alphabet, Eli ...

Intel stock is struggling for direction Friday after the chipmaker reported a fourth-quarter beat but gave weak guidance.

Amazon has joined Microsoft in offering access to Chinese startup DeepSeek's low-cost, open-source artificial intelligence training models. DeepSeek is challenging Meta in open-source models.

Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $32.08 Billion, which is 4.6x above the industry average, indicating ...